{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:36:03Z","timestamp":1715128563075},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,7]]},"DOI":"10.7759\/cureus.59830","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T18:12:20Z","timestamp":1715105540000},"source":"Crossref","is-referenced-by-count":0,"title":["Best Bisphosphonate Threshold for 10-Year Vertebral and Non-vertebral Fracture Mitigation"],"prefix":"10.7759","author":[{"given":"Samer M","family":"Alboun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Khreisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid E","family":"Alawneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled M","family":"Bani Hani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania F","family":"Khreisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed  A","family":"Al-Mughrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bara\u2019ah E","family":"Alshagoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabaa I","family":"Alfarajat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madher A","family":"Doumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mino","family":"Cycline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.53388\/AGING202305013","article-title":"Empowering women to combat osteoporosis: Unveiling the causes, consequences, and control strategies","volume":"5","author":"Enitan SS","year":"2023","unstructured":"Enitan SS, Adejumo BI, Adejumo EN, Olusanya TO, Osakue EO, Ladipo OA, Enitan CB. Empowering women to combat osteoporosis: Unveiling the causes, consequences, and control strategies. Aging Commun. 2023, 5:13. 10.53388\/AGING202305013","journal-title":"Aging Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007%2Fs40520-021-01817-y","article-title":"Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people.","volume":"33","author":"Barnsley J","year":"2021","unstructured":"Barnsley J, Buckland G, Chan PE, et al.. Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people. . Aging Clin Exp Res. 2021, 33:759-73. 10.1007%2Fs40520-021-01817-y","journal-title":"Aging Clin Exp Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00255","article-title":"Osteoporosis and sarcopenia increase frailty syndrome in the elderly","volume":"10","author":"Greco EA","year":"2019","unstructured":"Greco EA, Pietschmann P, Migliaccio S. Osteoporosis and sarcopenia increase frailty syndrome in the elderly. Front Endocrinol. 2019, 10:255. 10.3389\/fendo.2019.00255","journal-title":"Front Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00713-3","article-title":"Prevalence of frailty in older men and women: cross-sectional data from the Geelong Osteoporosis Study","volume":"107","author":"Tembo MC","year":"2020","unstructured":"Tembo MC, Holloway-Kew KL, Sui SX, et al.. Prevalence of frailty in older men and women: cross-sectional data from the Geelong Osteoporosis Study. Calcif Tissue Int. 2020, 107:220-9. 10.1007\/s00223-020-00713-3","journal-title":"Calcif Tissue Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05707-3","article-title":"Effect of compression fracture on trabecular bone score at lumbar spine","volume":"32","author":"Hsu Y","year":"2021","unstructured":"Hsu Y, Hsieh TJ, Ho CH, Lin CH, Chen CK. Effect of compression fracture on trabecular bone score at lumbar spine. Osteoporos Int. 2021, 32:961-70. 10.1007\/s00198-020-05707-3","journal-title":"Osteoporos Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14245\/ns.2346998.499","article-title":"Which indicator among lumbar vertebral hounsfield unit, vertebral bone quality, or dual-energy X-ray absorptiometry-measured bone mineral density is more efficacious in predicting thoracolumbar fragility fractures?","volume":"20","author":"Zhang B","year":"2023","unstructured":"Zhang B, Zhou LP, Zhang XL, et al.. Which indicator among lumbar vertebral hounsfield unit, vertebral bone quality, or dual-energy X-ray absorptiometry-measured bone mineral density is more efficacious in predicting thoracolumbar fragility fractures?. Neurospine. 2023, 20:1193-204. 10.14245\/ns.2346998.499","journal-title":"Neurospine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060966","article-title":"The pathophysiology, identification and management of fracture risk, sublesional osteoporosis and fracture among adults with spinal cord injury","volume":"13","author":"Craven BC","year":"2023","unstructured":"Craven BC, Cirnigliaro CM, Carbone LD, Tsang P, Morse LR. The pathophysiology, identification and management of fracture risk, sublesional osteoporosis and fracture among adults with spinal cord injury. J Pers Med. 2023, 13:966. 10.3390\/jpm13060966","journal-title":"J Pers Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.706","article-title":"Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus","volume":"12","author":"Palui R","year":"2021","unstructured":"Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes. 2021, 12:706-29. 10.4239\/wjd.v12.i6.706","journal-title":"World J Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0220-8","article-title":"Fracture prediction, imaging and screening in osteoporosis","volume":"15","author":"Fuggle NR","year":"2019","unstructured":"Fuggle NR, Curtis EM, Ward KA, Harvey NC, Dennison EM, Cooper C. Fracture prediction, imaging and screening in osteoporosis. Nat Rev Endocrinol. 2019, 15:535-47. 10.1038\/s41574-019-0220-8","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2021.1945027","article-title":"Fracture risk assessment by the FRAX model","volume":"25","author":"McCloskey EV","year":"2022","unstructured":"McCloskey EV, Harvey NC, Johansson H, et al.. Fracture risk assessment by the FRAX model. Climacteric. 2022, 25:22-8. 10.1080\/13697137.2021.1945027","journal-title":"Climacteric"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4134","article-title":"Defining very high fracture risk: Is FRAX fit for purpose?","volume":"35","author":"Compston JE","year":"2020","unstructured":"Compston JE, Drake MT. Defining very high fracture risk: Is FRAX fit for purpose?. J Bone Miner Res. 2020, 35:1399-403. 10.1002\/jbmr.4134","journal-title":"J Bone Miner Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1253-y","article-title":"Development and use of FRAX in osteoporosis","volume":"21","author":"Kanis JA","year":"2010","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Str\u00f6m O, Borgstr\u00f6m F. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010, 21:S407-13. 10.1007\/s00198-010-1253-y","journal-title":"Osteoporos Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis JA","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008, 19:385-97. 10.1007\/s00198-007-0543-5","journal-title":"Osteoporos Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00954-1","article-title":"The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults","volume":"16","author":"Bhadada SK","year":"2021","unstructured":"Bhadada SK, Chadha M, Sriram U, et al.. The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults. Arch Osteoporos. 2021, 16:102. 10.1007\/s11657-021-00954-1","journal-title":"Arch Osteoporos"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-016-0278-z","article-title":"A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation","volume":"11","author":"Kanis JA","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Od\u00e9n A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline Group. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016, 11:25. 10.1007\/s11657-016-0278-z","journal-title":"Arch Osteoporos"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black DM","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, et al.. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020, 383:743-53. 10.1056\/NEJMoa1916525","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25190","article-title":"Bisphosphonate treatment beyond 5 years and hip fracture risk in older women","volume":"3","author":"Izano MA","year":"2020","unstructured":"Izano MA, Lo JC, Adams AL, et al.. Bisphosphonate treatment beyond 5 years and hip fracture risk in older women. JAMA Netw Open. 2020, 3:e2025190. 10.1001\/jamanetworkopen.2020.25190","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247477","article-title":"Advancement in the treatment of osteoporosis and the effects on bone healing","volume":"11","author":"Kushchayeva Y","year":"2022","unstructured":"Kushchayeva Y, Pestun I, Kushchayev S, Radzikhovska N, Lewiecki EM. Advancement in the treatment of osteoporosis and the effects on bone healing. J Clin Med. 2022, 11:7477. 10.3390\/jcm11247477","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.02.009","article-title":"2018 update of French recommendations on the management of postmenopausal osteoporosis","volume":"85","author":"Briot K","year":"2018","unstructured":"Briot K, Roux C, Thomas T, et al.. 2018 update of French recommendations on the management of postmenopausal osteoporosis. Joint Bone Spine. 2018, 85:519-30. 10.1016\/j.jbspin.2018.02.009","journal-title":"Joint Bone Spine"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S112621","article-title":"Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: Considerations for women\u2019s health practice","volume":"8","author":"Cheung AM","year":"2016","unstructured":"Cheung AM, Frame H, Ho M, Mackinnon ES, Brown JP. Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: Considerations for women\u2019s health practice. Int J Womens Health. 2016, 8:537-47. 10.2147\/IJWH.S112621","journal-title":"Int J Womens Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00931-8","article-title":"FRAX-based osteoporosis treatment guidelines for resource-poor settings in India","volume":"16","author":"Nagendra L","year":"2021","unstructured":"Nagendra L, Bhavani N, Menon VU, et al.. FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Arch Osteoporos. 2021, 16:69. 10.1007\/s11657-021-00931-8","journal-title":"Arch Osteoporos"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.6977","article-title":"Bone density screening intervals for osteoporosis: One size does not fit all","volume":"307","author":"Yu EW","year":"2012","unstructured":"Yu EW, Finkelstein JS. Bone density screening intervals for osteoporosis: One size does not fit all. JAMA. 2012, 307:2591-2. 10.1001\/jama.2012.6977","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-013-0074-1","article-title":"Bone mineral density evaluation in osteoporosis: Why yes and why not?","volume":"25","author":"Celi M","year":"2013","unstructured":"Celi M, Rao C, Scialdoni A, Tempesta V, Gasbarra E, Pistillo P, Tarantino U. Bone mineral density evaluation in osteoporosis: Why yes and why not?. Aging Clin Exp Res. 2013, 25:S47-9. 10.1007\/s40520-013-0074-1","journal-title":"Aging Clin Exp Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.J.00160","article-title":"Hounsfield units for assessing bone mineral density and strength: A tool for osteoporosis management","volume":"93","author":"Schreiber JJ","year":"2011","unstructured":"Schreiber JJ, Anderson PA, Rosas HG, Buchholz AL, Au AG. Hounsfield units for assessing bone mineral density and strength: A tool for osteoporosis management. J Bone Joint Surg Am. 2011, 93:1057-63. 10.2106\/JBJS.J.00160","journal-title":"J Bone Joint Surg Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08323-9","article-title":"Diagnostic accuracy of quantitative dual-energy CT-based volumetric bone mineral density assessment for the prediction of osteoporosis-associated fractures","volume":"32","author":"Gruenewald LD","year":"2022","unstructured":"Gruenewald LD, Koch V, Martin SS, et al.. Diagnostic accuracy of quantitative dual-energy CT-based volumetric bone mineral density assessment for the prediction of osteoporosis-associated fractures. Eur Radiol. 2022, 32:3076-84. 10.1007\/s00330-021-08323-9","journal-title":"Eur Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245351-best-bisphosphonate-threshold-for-10-year-vertebral-and-non-vertebral-fracture-mitigation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T18:12:24Z","timestamp":1715105544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245351-best-bisphosphonate-threshold-for-10-year-vertebral-and-non-vertebral-fracture-mitigation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.59830","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}